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Abstract 
Background: Laparoscopic ileo-pouch-anal anastomosis (IPAA) has been reported as having low 
morbidity and several advantages.  
Aims: To evaluate safety, efficacy and long-term results of laparoscopic IPAA, performed in elective 
or emergency settings, in consecutive unselected IBD patients.  
Methods: All the patients received totally laparoscopic 2-stage (proctocolectomy and IPAA – stoma 
closure) or 3-stage (colectomy – proctectomy and IPAA – stoma closure) procedure according to 
their presentation.  
Results: From July 2007 to July 2016, 160 patients entered the study. 50.6% underwent a 3-stage 
procedure and 49.4% a 2-stage procedure. Mortality and morbidity were 0.6% and 24.6%. Conversion 
rate was 3.75%. 8.7% septic complications were associated with steroids and Infliximab treatment 
(p=0.0001). 3-stage patients were younger (p=0.0001), with shorter disease duration (p=0.0001), 
minor ASA scores of 2 and 3 (p=0.0007), lower inflammatory index and better nutritional status 
(p=0.003 and 0.0001), fewer Clavien-Dindo’s grade II complications (p=0.0001), reduced rates of  
readmission and reoperation at 90 days (p=0.03), and shorter hospitalization (p=0.0001), but with 
similar pouch and IPAA leakage, compared to 2-stage patients. 8 years pouch failure and definitive 
ileostomy were 5.1% and 3.7%. 
Conclusion: A totally laparoscopic approach is safe and feasible, with very low mortality and 
morbidity rates and very low conversion rate, even in multi-stage procedures and high-risk patients. 
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1. Introduction 
Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) was first described by Parks 
and Nicholls in 1978, and it has since become the treatment of choice for familial adenomatous 
polyposis (FAP), ulcerative colitis (UC), indeterminate colitis (IC) and selected cases of Crohn’s 
Disease (CD)1-3. In inflammatory bowel disease (IBD), restorative proctocolectomy with IPAA is 
usually performed electively in one or two stages, depending on whether a temporary ileostomy is 
created. Abdominal colectomy is advocated prior to IPAA procedure in high-risk patients and in 
emergency settings2.  
Restorative proctocolectomy remains a highly technically demanding operation with reported peri-
operative morbidity and mortality rates of 15%-50% and 1%-13%, respectively4-10. Laparoscopy has 
been proposed as an appealing alternative to open surgery for IPAA, and it has been found to be 
associated with a reduction in post-operative complications, less intraoperative blood loss, earlier 
recovery, shorter length of hospitalization, reduction in visceral adhesions and incisional hernias, 
improved cosmesis, and better preservation of female fecundity, in comparison with open surgery11-
15. However, totally laparoscopic restorative proctocolectomy with IPAA, especially if performed in 
multiple stages, is a quite complex procedure, and few studies in tertiary centers have prospectively 
evaluated a totally laparoscopic approach, in elective or emergency settings, and in a consistent 
number of consecutive and unselected IBD patients16-20.  
The aim of the present study was to evaluate safety, efficacy and long-term results of totally 
laparoscopic, multi-stage IPAA, in a consecutive, unselected series of IBD patients referred to a 
tertiary Italian center. 
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2. Patients and Methods 
A defined diagnostic, therapeutic and clinical care protocol (in Italian: Percorso Diagnostico 
Terapeutico Assistenziale – PDTA) was established in January 2008, to offer a high-quality standard 
of surgical care, in line with international guidelines, and to provide a management and accounting 
tool for auditing. A Multi-Disciplinary Team (MDT) for IBD was already present, involving 
gastroenterologists, surgeons, paediatricians, pathologists and radiologists. Oncologists, 
ophthalmologists and infectious disease specialists were also involved for selected cases. A dedicated 
service was also guaranteed by stoma-therapists, nutritionists, and psychologists. A 24-hour joint 
surgery and gastroenterology IBD on-call service was already available. In all patient candidates for 
emergency or elective surgery, a multi-disciplinary meeting (MDM) evaluation was performed, 
involving the surgical team that had an experience of performing more than 250 IPAA by open 
approach, as well as advanced training in laparoscopic colorectal surgery. A dedicated, prospective 
database was set up and approved by the ethics committee of our institution, including 75 variables 
concerning demographic, pre-operative, peri-operative, and long-term data. Follow-up was 
maintained with clinical examinations at 3, 6 and 12 months after surgery, and then yearly or in case 
of necessity. Functional results were evaluated at 12 months. All patients received an endoscopic 
control of the pouch at 12 months and then every 2 years or in case of necessity. Informed consent 
for the surgical procedures and data auditing was obtained from all patients after specific 
multidisciplinary counselling.  
2.1. Emergency settings 
Emergency surgery was indicated in all patients with severe acute colitis refractory to salvage therapy 
or with surgical complications (fulminant colitis, perforation, massive haemorrhage, toxic 
megacolon). Severe acute colitis was defined using the Truelove and Witts criteria, as reported in the 
European Crohn’s and Colitis Organization (ECCO) and American Society of Colon and Rectal 
Surgeons (ASCRS) Guidelines2,21-26. To exclude the risk for toxic dilation or to monitor response to 
therapy, a computed tomography (CT) scan and/or bowel ultrasound, instead of plain abdominal x-
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ray, was performed in most cases27,28. At hospital admission, all patients were evaluated jointly by a 
dedicated gastroenterologist and surgeon at most within 24 hours, based on clinical, biochemical and 
radiological examinations. Patients were considered as candidates for immediate surgical procedure 
or re-evaluation after rescue therapy with intravenous steroids at 72 hours, based on clinical history. 
Patients with an indication for second line medical treatment with cyclosporine or Infliximab were 
re-evaluated at the 5th, and no later than the 7th day. In the case of no improvement or worsening, 
surgery was performed in urgent or emergency settings by means of total abdominal colectomy, rectal 
closure, and Brooke’s ileostomy2,29,30. 
2.2. Elective settings 
Indications for elective surgery were chronic refractory colitis, complicated or refractory CD of the 
colon, chronic obstruction, and malignant transformation2,31. For patients referred from other 
hospitals, a specific discussion with the proposing gastroenterologist or paediatrician was performed 
and the complete case reviewed, including reviewing previous biopsies from the referral pathologist 
(PF) when necessary. According to patient characteristics, restorative proctocolectomy was 
performed in 1, 2 or 3 stages.  The 3-stage procedure consisted of abdominal colectomy and rectal 
closure with Brooke’s ileostomy30, followed by completion proctectomy, formation of IPAA and loop 
ileostomy, and ileostomy closure. The 3-stage procedure included also the elective completion 
proctectomy of those patients treated in the emergency setting by abdominal colectomy. The 2-stage 
procedure refers to a proctocolectomy with IPAA and loop ileostomy followed by closure of 
ileostomy. In the modified 2-stage and in the single-stage procedures ileostomy was omitted at time 
of restorative completion proctectomy and proctocolectomy respectively2,29,32-35. 
2.3. Study population 
All consecutive patients referred to the IBD Surgical Unit for restorative proctocolectomy were 
considered eligible for the study. Candidate patients for open surgery due to previous major 
abdominal procedures or with contraindications to laparoscopy, and those treated by ileo-rectal 
anastomosis or proctocolectomy with definitive ileostomy, were not included. Previous open 
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appendectomy, cholecystectomy, gynaecological and urological procedures were not considered as 
contraindications to the laparoscopic approach. Patients who required conversion during the first 
laparoscopic procedure were considered for an “intention to treat” analysis in terms of morbidity and 
mortality, but then excluded from analysis of the following step according to “per protocol” analysis. 
In the emergency setting, hemodynamically unstable or perforated patients were candidates for open 
colectomy and thus were excluded from the study2. Toxic megacolon was not considered an absolute 
contraindication to laparoscopic colectomy. As previously reported and in accordance with European 
and North American Guidelines, aging was not considered itself a contraindication to laparoscopic 
restorative proctocolectomy2,24,36. A complete record of each patient with pre-operative, intra-
operative, post-operative and long-term results was entered in the data base.  Readmission and 
reoperation were considered within 90 days. Conversion into laparotomy was defined as an unplanned 
abdominal incision longer than 6cm in any abdominal quadrant. Long-term results were recorded in 
terms of functional results at 12 months, and diagnosis of pouchitis, IPAA stenosis or fistulisation, 
and pouch failure during follow-up. 
2.4. Surgical procedures 
All patients were treated by a totally laparoscopic approach using a five-trocars technique (Figure 1). 
Vascular ligations were always performed at major trunks (inferior mesenteric artery and vein, 
middle-, right-, and ileo-colic vessels), from left side to right side, avoiding peri-visceral dissection, 
in order to minimize intestinal mucosal ischemia, with loss of barrier function, and consequent 
intraoperative systemic toxicity37. The rectal stump was always managed with intra-corporeal stapling 
and overlock running suture. Total mesorectal excision (TME) and carcinogenic mesocolic excision 
were performed in the cases of dysplasia or colorectal cancer (CRC). Incomplete TME (I-TME), 
where the dissection was carried out in the pre-sacral plane posteriorly and close to the rectum in the 
anterior and lateral planes, was used in all other patients. All pouches were 15-18cm long, stapled J-
pouch as designed by Utsunomiya in 198038. The ileo-pouch-anal anastomosis was performed by a 
Knight-Griffen39, transanal anastomosis, using a circular end-to-end stapling device (CEEA), with 
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intraoperative measurement of the distance from the dentate line between 1cm and 2cm. A hand-sewn 
anastomosis, with transanal mucosectomy, was performed when necessary (low rectal dysplasia or 
CRC, failure of the CEEA stapler device)2,40. Extraction of the specimen and pouch creation were 
performed through the site of the temporary ileostomy in the right iliac fossa, or through a peri-
umbilical or a suprapubic incision, depending on the dimension of the specimen or the need for 
mesenteric lengthening of the pouch. In the patients undergoing the 3-stage procedure, the same ports 
and extraction site were used for abdominal colectomy (stage 1) and completion proctectomy with 
IPAA (stage 2) (Figure 1). The completion proctectomy with IPAA and loop ileostomy were 
performed between 3 and 6 months after abdominal colectomy, rectal closure and ileostomy. This 
time interval is based on the need to obtain adequate steroid tapering, desaturation from any 
pharmacological compounds, and normalization of nutritional status. Temporary ileostomy was 
closed at 6-8 weeks with a wide lumen, functional end-to-end, stapled anastomosis, after clinical 
examination. Control of the pouch and IPAA was performed by pelvic magnetic resonance imaging 
(MRI) prior to ileostomy closure only in selected cases with a clinical or biochemical suspicion of 
dehiscence.  
2.5. Outcome measures 
Perioperative mortality and morbidity were considered during hospital stay and within 90 days after 
each step of 1, 2 or 3-stage surgical procedures. Postoperative complications were classified using 
the Clavien-Dindo’s classification41-43. Major surgical complications were defined as Clavien-
Dindo’s grade III or IV, while grade V corresponds to mortality. Intra-abdominal septic complications 
(IASC), including pelvic sepsis, were particularly evaluated. Functional results were considered in 
terms of frequency of bowel movements over 24 hours, and diurnal and/or nocturnal soiling and/or 
incontinence, at 12 months after ileostomy closure. Long-term complications were defined as any 
adverse event related to the surgical procedure occurring during the follow-up. The minimum follow-
up was 12 months. Pouchitis was defined as an inflammation of the pouch in the presence of 
symptoms associated with endoscopic and histopathologic findings2.  Pouch failure was defined as 
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excision or indefinite defunctioning of the pouch2. A comparison was performed between 2- and 3-
stage procedures in terms of cumulative early and late postoperative results referred to IPAA creation. 
2.6. Statistical analysis  
Comparison of proportions was performed using chi-square or Fisher’s exact test where appropriate. 
Continuous variables were analysed using Student’s t test. Long term pouch survival was calculated 
with the time-to-event Kaplan and Meier estimates. This study was approved and conducted 
according to the ethical standards of the ethics committee of our institution, and reported according 
to the Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] 
guidelines44. 
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Results 
From January 2008 to December 2016, 204 patients entered the diagnostic, therapeutic and clinical 
care protocol (PDTA) at “Luigi Sacco” University Hospital. According to patient selection criteria, 
44 patients were excluded from this survey: 20 patients (9.8%) were candidates for open surgery due 
to previous major laparotomy or clinical contraindications to pneumoperitoneum, 14 patients (8.7%) 
received an IRA or permanent ileostomy (78.5% of these patients were also treated by laparoscopy), 
and 10 patients (4.9%) were perforated or hemodynamically unstable and thus operated on using an 
open approach. The total percentage of patients considered unsuitable for the laparoscopic approach 
was 16.1% (of all 204 patients). In the remaining 160 patients, 231 major abdominal procedures and 
136 ileostomy closures were performed. There were 100 males (62.5%), 13 patients (8.1%) presented 
extra-intestinal manifestations of IBD, 11 (6.8%) had a family history of IBD, 12 (7.5%) were active 
smokers, and 21 (13.1%) received a previous abdominal surgery. Preoperative diagnosis of UC was 
present in 153 patients (95.6%), CD in 4 (2.5%), and IC in 3 (1.9%), while 31 (19.3%) patients were 
operated on for dysplasia or CRC. The mean age at diagnosis was 38.1 ±16.3 years (min 5, max 80 
years), the mean age at first-stage surgical procedure was 48 ±16.1 years (min 15, max 82 years), and 
the mean disease duration was 10.1 ±8.9 years. Disease extension was a pancolitis in 92.5% and a 
left-sided colitis or proctitis in 7.5%. 81 patients (50.6%) underwent a sub-total colectomy, 47 of 
them (58%) in the emergency setting due to severe acute colitis, 8 for toxic megacolon (9.9%), and 
the remaining 26 for poor clinical conditions (32.1%). One female patient died on post-operative day 
2, after emergency colectomy, for ictus cerebri at the age of 80 years (mortality rate 1.2%). Three 
patients were converted to open surgery (conversion rate 3.7%), and 6 patients have not yet completed 
the following stages. Characteristics of the patients submitted to abdominal colectomy, rectal closure 
and ileostomy are reported in Table 1. Seventy-one patients received completion proctectomy and 
IPAA with a conversion rate of 2.8% (2 patients), and 5 of them (7.1%) without diversion by 
temporary ileostomy (modified 2-stage procedure). Seventy-nine patients (49.4%) were operated on 
by a 2-stage (72 patients – 91.1%) or a single-stage procedure (7 patients – 8.9%). The overall rate 
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of patients without diversion at the time of pouch and IPAA formation was 8% (7 single-stage + 5 
modified 2-stage).  Comparisons of patient characteristics at time of completion proctectomy or 
restorative proctocolectomy are reported in Table 2.  Intra-abdominal septic complications (IASC), 
including pelvic sepsis, occurred in 14 patients (8.7%), 5 (6.2%) at the time of colectomy, 2 (2.8%) 
at the time of completion proctectomy, and 7 (8.8%) after proctocolectomy. Comparing patients with 
IASC with patients with other or no complications, 57.1% vs. 16.2% were treated with a combination 
of systemic steroids and Infliximab, 28.6% vs. 24.3% with systemic steroids alone, and 14.3% vs. 
59.5% were being treated with another or no therapeutic regimen (p=0.0001). 
The conversion rate in the 3-stage procedure (stage 1 + stage 2) was 3.3%, and in all single and multi-
stage procedures was 3.75%. Complications at ileostomy closure are listed in Table 3. Mortality rate 
at 90 days in 1, 2, or 3-stage procedures was 0.6%. Long-term results and the cumulative probability 
of the first episode of pouchitis, pouch failure, and definite ileostomy are reported in Figure 2. 
 
Discussion 
A multidisciplinary approach, which includes formal multidisciplinary meetings and allows for 
integration of the contributions of all specialists necessary for adequate treatment of IBD patients, is 
of paramount importance for tertiary standard of care. Performing such a complex surgical PDTA 
requires significant design and organization, medical and nursing staff upgrading, and, above all, a 
change in mentality. A very aggressive policy in terms of early multidisciplinary discussions, re-
evaluation and surgery is necessary to achieve low morbidity and mortality rates45-47. Success also 
depends upon prospective auditing of patients concerning timing and indication for surgery, 
intraoperative critical issues, perioperative complications, and long-term results, in order to verify 
results and update strategies48. Selection criteria for patients who are candidates for laparoscopy for 
elective or emergency procedures are rarely reported in the literature. In this series, the patients were 
consecutive and unselected, and the only reason for an open procedure, apart from clinical 
contraindications, was previous major open abdominal surgery. Applying these criteria, 
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contraindication to laparoscopy was 16.1%, but conversion rate was very low (3.75%), considering 
that reported conversion rate in trials and observational studies ranges from 1 to 23%49-56, and that 
conversion rate after laparoscopic cholecystectomy, the most popular laparoscopic procedure, is 
reported to be 5-10%57.  Emergency sub-total colectomy for acute colitis in IBD is a potentially life-
threatening procedure, with a reported mortality rate that ranges, in Europe and North America, from 
1% to 13%4-6,46. In 2006, the United Kingdom national audit of IBD identified a mortality rate of 2.1-
4.7% after emergency colectomy46. In 2012, Tottrup et al., in the Danish population-based nationwide 
cohort study of 2889 cases, showed a 30-day mortality of 5.2% after emergency colectomy and 0.9% 
after elective proctocolectomy for UC, and 8.1% and 1.5% for CD5. In 2015, an audit of 1166 patient 
from 237 French centers found a mortality rate of 1.5% (0-2.7%)6,58 after elective restorative 
proctocolectomy. However, the vast majority of patients in all these series were operated on in the 
1990’s, and in the early 2000’s by open procedures. Only 8 studies reported on mortality after 
laparoscopic colectomy, with a rate of 0.25% in a total of 402 patients47. The most important 
prognostic factors for mortality are the volume of the center, the surgeon’s experience and the timing 
of surgery, given that high-volume centers (>10 cases per year), with dedicated surgeons and with 
aggressive surgical policies, have reported mortality rates around 2% for emergency surgery and 1% 
for elective surgery36,45-47,52,54,59-64.  Morbidity is subject to the same prognostic factors of mortality 
and remains quite high in almost all the series. Expected morbidity ranges from 25% to 65%, but 
major complications have shown a tendency to decrease over years, in particular after laparoscopic 
procedures performed in referral centers6,11,47,59,65. In most studies, complications are reported as a 
description, limiting the possibility of adequate comparisons. Unfortunately, even if the Clavien-
Dindo classification should be used, some specific limitations in the field of IBD are present41-43. In 
fact, the Clavien-Dindo classification has been designed to provide grading of complications after 
elective abdominal surgery. Accordingly, any deviation from the normal postoperative course, such 
as prolonged ileus or simple wound infections, are classified as Grade 1 complications, while blood 
transfusion and total parenteral nutrition (TPN) are classified as Grade 2. However, these therapeutic 
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regimens are the daily clinical practice for IBD patients, both in emergency and some elective 
settings. As shown in Table 1, Grade I and II complications after colectomy are 58%, but if blood 
transfusions and TPN are excluded, these complications only make up 8.6%. Similarly, as shown in 
Table 2, they change from 32.9% to 6.3% after restorative proctocolectomy. Another limitation of 
the Clavien-Dindo classification is that it accounts only for complication during hospitalization. 
Readmission and reoperation after discharge, another common aspect of IBD patients, is rarely 
reported in surgical series and generally within 30 days7,66,67. Extension of the observation period to 
90 days is more indicative of the course of IBD patients48. The vast majority of readmission and 
reoperation after colectomy and proctocolectomy are related to ileostomy complications (ileus, 
obstruction, dehydration and electrolyte imbalance). Some authors have proposed to omit diversion 
after ileal pouch surgery to avoid stoma-related complications, but at the cost of a 3-fold greater (5% 
to 15%) incidence of IPAA leakage and pouch-related sepsis68-72. In the present series, the 5.3% 
cumulative incidence of leakage is quite low, with 8% of the patients without diversion. The 6% 
incidence of IASC was strongly related to treatment with steroids in association with Infliximab, as 
previously reported73-77. However, both leakage and IASC were independent of the number of 
surgical stages.  Determining the right timing for restorative proctocolectomy and deciding on a single 
or a staged procedure remains the crucial issue of this surgery, since the majority of complications, 
including mortality, could be a consequence of this initial decision. To date, only 5 studies have 
focused on the comparison between the 2 and 3-stage approach: one from the same inventor of the 
pouch (RJ Nicholls)18, 3 with the series dating back to the 1980’s18-20, one with a laparoscopic 
approach in 17.4% of the cases (25 patients)78, and only a recent one using the total laparoscopic 
approach in a consistent number of patients65. Hicks et al. concluded in favour of the predominant 
use of 2-staged surgery, but the patients who underwent the 3-stage procedure in the study only 
totalled 28, and only 7 were treated by laparoscopy78. Galandiuk et al. also favored 2 stages in their 
series of 871 patients, while Nicholls and Penna suggested the 3-stage procedure was safer, but all 
the patients were operated on by open surgery in the pre-anti-TNF era18-20. The results from the group 
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of Clichy, who used laparoscopy in 100% of 185 patients, are very similar to the results in this study, 
in particular in terms of patient characteristics, operative findings, perioperative complications and 
postoperative results (Table 1 and 2). However, some interesting differences should be highlighted65. 
A direct comparison of the 2- and 3-stage procedures is quite difficult as it involves different patients 
with different indications. However, focusing on the construction and anastomosis of the pouch, there 
are major differences between patients who have previously had a colectomy (who have passed the 
risks of surgery in emergency or in poor clinical conditions) and those who are candidates for 
proctocolectomy. In fact, the latter have a higher ASA score, an altered inflammatory and nutritional 
status, and most of them are receiving maximal medical treatment, as well as have a higher 90-day 
readmission and reoperation rate (Table 2). These results suggest that perhaps a subset of the patients 
who were candidates for proctocolectomy would have benefited from a staged procedure. 
Furthermore, a higher ASA score and longer hospitalization are still factors at the time of 
recanalization. However, no differences are present in terms of IPAA and pouch leakage. In the past, 
an attempt to reduce the number of procedures appeared to be indicated by the morbidity associated 
with multiple laparotomies, but in different surgical fields, such as cholecystectomy, bariatric surgery 
and gastroesophageal reflux disease, laparoscopy has changed the indications by reducing the 
morbidity in comparison with previous treatments.  
In this context the proposal by some Authors to carry out a modified two-stage procedure, without 
diverting the patient at the time of completion proctectomy, appears very intriguing. In our experience 
only 7% of the patients underwent this procedure, but in the future the combination of a laparoscopic 
approach with a modified two-stage procedure should be studied in more depth32-35. 
The possibility to perform a restorative proctocolectomy by a laparoscopic approach, with very low 
morbidity, morality, conversion rate and long-term results, regardless of the number of the stages, 
should allow for debate in the future about the possibility of having an evidence-based driven staging 
for IPAA surgery. 
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Table 1. Patients submitted to abdominal colectomy, rectal closure and ileostomy [¶ Clavien-Dindo’s complications of 
grade I and II excluding perioperative blood transfusion and total parenteral nutrition (TPN)]. 
 
Number of patients 81 
Age  44 ± 17 years 
Gender Males Females 
50 (61,7%) 
31 (39,3%) 
Extra-intestinal Manifestations of IBD 8 (9,8%) 
Familiarity for IBD 4 (4,9%) 
Smoking Habit 6 (7,4%) 
Diagnosis  
Ulcerative Colitis 
Crohn’s Disease  
Indeterminate Colitis 
76 (93,8%) 
2 (2,4%) 
3 (3,8%) 
Age  44 ± 17 years 
Age at Diagnosis (years) 37,8 ± 16,5 years 
Disease Duration (years) 6 ± 6,47 years 
ASA Score 
ASA1 
ASA2 
ASA3 
10 (12,3%) 
61 (75,3%) 
10 (12,4%) 
Previous Abdominal Surgery 8 (9,8%) 
Preoperative Therapy 
5-ASA 5 (6,2%) 
Steroids 26 (32%) 
Combined Therapy 17 (21%) 
Biologics 26 (32%) 
Cyclosporine 7 (8,8%) 
Preoperative Blood Exams 
Haemoglobin (g/dL) 10,3 ± 1,99 
White Cell Count (u/L) 9411 ± 3670 
C Reactive Protein (mg/dL) 41,2 ± 45,7 
Total Proteins (g/L) 5,56 ± 0,85 
Albumin (g/L) 28 ± 6,7 
Transthyretine (g/L) 0,14 ± 0,05 
Indication for Surgery 
Refractory to Medical Therapy 
Severe Acute Colitis  
Toxic Megacolon 
26 (32,1%) 
47 (58%) 
8 (9,9%) 
Operative Time (minutes) 211 ± 60,6 
Conversion Rate  3 (3,7%) 
Specimen Delivery 
Suprapubic Incision 
Stoma Site 
Peri-umbilical  
37 (45,6%) 
42 (51,8%) 
2 (2,6%) 
Complications (Clavien-Dindo) 
Grade I+II 
            IIIA 
            IIIB 
            IV 
            V 
47 (58%) – 7 (8,6%)¶ 
3 (3,8%) 
2 (2,4%) 
/ 
1 (1,2%) 
Readmission (90 days) 11 (13,5%) 
Reoperation (90 days) 6 (7,4%) 
Hospitalisation (days) 15,2 ± 7,8 
 
 
Table 2. Patients submitted to completion proctectomy or proctocolectomy with pouch construction and IPAA (the 
following parameters relate to the 1st stage: ASA Score¶, medical therapy†, readmission and reoperation*; summation 
of 1st and 2nd stage operative times §; Clavien-Dindo’s stages I and II excluding perioperative blood transfusion and TPN#; 
considering only Clavien-Dindo’s stages III-V‡; and hospitalisation^). 
 
 Completion Proctectomy n 71 Proctocolectomy n 79 p value 
Age 42,6 ± 15,5 51,3 ± 14 0,0001 
Gender 
 Males 
 Females 
 
42 (59,1%) 
29 (40,9%) 
 
50 (63,3%) 
29 (36,7%) 
 
 
0,72 
Extra-intestinal Manifestations of IBD 8 (11,2%) 5 (6,9%) 0,43 
Familiarity for IBD 4 (5,6%) 7 (8,8%) 0,65 
Smoking Habit 6 (8,4%) 6 (7,5%) 0,92 
Diagnosis  
 Ulcerative Colitis 
 Crohn’s Disease 
 Indeterminate Colitis 
 
66 (92,9%) 
2 (2,8%) 
3 (4,3%) 
 
77 (97,4%) 
2 (2,6%) 
0  
 
 
 
0,28 
Age at Diagnosis (years) 36,5 ± 15 37,8 ± 16,3 0,6 
Disease Duration (years) 6 ± 6,4 13,6 ± 9,1 0,0001 
ASA Score 
 ASA1 
 ASA2 
 ASA3 
 
30 (42,2%) 10 (12,3%)¶ 
40 (56,4%) 61 (75,3%)¶ 
1 (1,4%)  10 (12,4%)¶ 
 
11 (13,9%)¶ 
58 (73,4%)¶ 
10 (12,7%)¶ 
 
 
 
0,0007 - 0,9¶ 
Previous Abdominal Surgery 6 (8,4%) 13 (16,4%) 0,22 
Preoperative Therapy 
 5-ASA 
 Steroids 
 Combined Therapy 
 Biologics 
 Cyclosporin 
 
/  5 (6,2%)† 
/  26 (32%)† 
/  17 (21%)† 
/  26 (32%)† 
/  7 (8,8%)† 
 
13 (16,4%) 
15 (18,9%) 
16 (20,2%) 
21 (26,5%) 
1 (1,6%) 
 
 
 
 
 
0,03 
Preoperative Blood Exams 
 Haemoglobin (g/dL) 
 C Reactive Protein (mg/dL) 
 Total Proteins (g/L) 
 Albumin (g/L) 
 Transthyretine (g/L) 
 
12,9 ± 1,2 
2 ± 1,3 
6,8 ± 0,96 
4 ± 0,78 
0,22 ± 0,03 
 
12,23 ± 2,07 
13,7 ± 25,8 
6,35 ± 0,89 
3,5 ± 0,7 
0,20 ± 0,05 
 
0,7 
0,0002 
0,003 
0,0001 
0,003 
Operative Time (minutes) 186,6 ± 56,7  352 ± 91,5§ 325,75 ± 86,25§ 0,07§ 
IPAA  
 Hand sewn 
 Stapled 
 
2 (2,9%) 
69 (97,1%) 
 
5 (6,4%) 
74 (93,6%) 
 
 
0,44 
Conversion Rate 2 (2,8%) 1 (1,6%) 0,6 
Specimen Delivery 
 Suprapubic Incision 
 Stoma Site 
 Peri-umbilical 
 
30 (42,2%) 
40 (56,4%) 
1 (1,4%) 
 
41 (51,9%) 
36 (45,5%) 
2 (2,6%) 
 
 
 
0,43 
Complications (Clavien-Dindo) 
 Grade I+II 
             IIIA 
             IIIB 
             IV 
 
3 (4,3%) 
2 (1,4%) 
2 (1,4%) 
/  4 (5,6%)‡ 
 
26 (32,9%) – 5 (6,3%)# 
2 (2,6%) 
5 (6,3%) 
1 (1,2%)         8 (10,1%)‡ 
 
 
 
 
0,0001 - 0,89‡ 
Defunctioning Ileostomy 66 (92,9%) 72 (91,1%) 0,92 
IPAA leakage 2 (2,9%) 4 (5%) 0,68 
Pouch Leakege 1 (1,4%) 1 (1,6%) 1 
Readmission (90 days) 2 (2,9%)  11 (13,5%)* 10 (12,7%)*  0,03 - 1* 
Reoperation (90 days) 1 (1,4%)  6 (7,4%)* 8 (10,1%)*  0,03 - 0,58* 
Hospitalisation (days) 9,1 ± 3,2 15,2 ± 7,8  ^ 13,9 ± 7,2  ^ 0,0001 – 0,2^ 
 
Table 3. Patients submitted to ileostomy closure after 2 or 3 stages procedure. 
 
 3-stages n 66  2-stages n 70 p value 
Gender 
 Males 
 Females 
 
42 (63.6%) 
24 (36.4%) 
 
46 (65.7%) 
24 (34.3%) 
 
 
0,9 
ASA Score 
 ASA1 
 ASA2 
 ASA3 
 
30 (45.5%) 
36 (54.5%) 
0 
 
10 (14.2%) 
52 (74.2%) 
8 (11.6%) 
 
 
 
0,0001 
Previous Abdominal Surgery 6 (9%) 11 (15.7%) 0,03 
Complications (Clavien-Dindo) 
 Grade I+II 
             IIIA 
             IIIB 
 
1 (1.5%) 
0 
0 
 
3 (4.3%) 
0 
3 (4.3%) 
 
 
 
0,1 
Readmission (90 days) 1 (1.5%) 1 (1.4%) 1 
Reoperation (90 days) 1 (1.5%) 1 (1.4%) 1 
Hospitalisation (days) 6,6 ± 4,4 9.2 ± 4.6 0,0001 
 
Figure 1. Trocar positioning and ports utilisation during 1st and 2nd stage. 
 
 
 
 
Figure 2. Upper panel: Kaplan-Meier time-to-event estimates of Pouch Failure (left) and Permanent Ileostomy (right). 
Lower panel: Kaplan-Meier time-to-event estimates of first episode of Pouchitis (left) and functional results (right) 
 
  
 
Stool Frequency 
 Day  
 Night 
Soiling 
 Day 
 Night 
Incontinence 
 Day 
 Night 
Pouch Failure 
 n (%) 
 Cumulative probability 
Redo Pouch 
 n (%) 
Definitive Ileostomy 
 n (%) 
 Cumulative probability 
Length of Follow-up (years ±SD) 
 
5 (2-10) 
1 (0-2) 
 
5% 
16% 
 
/ 
/ 
 
7 (5,1%) 
7% at 8 years 
 
2 (28,5%) 
 
5 (3,7%) 
4% at 8 years 
5,1 ±2,5 
  
